Danbo Wang

机构：Qinghai University, Qingdao University of Science and Technology, Chongqing University, Sichuan University, Shenyang Fifth People Hospital, Chongqing Cancer Hospital, Liaoning Cancer Hospital & Institute · ORCID：0000-0002-8925-364X

发表论文 227 篇 · 总被引 2610 次 · h-index 27

代表论文

• Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer (2025 · New England Journal of Medicine · 被引 26)
• pH-responsive 2D niobium carbide nanosheets for targeted circPUM1 siRNA delivery in ovarian cancer therapy (2025 · Materials Today Bio · 被引 5)
• Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial (2026 · Nature Cancer · 被引 3)
• Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial (2025 · CA A Cancer Journal for Clinicians · 被引 3)
• Clinical characteristics of vulvar basal cell carcinoma: a multi-center, retrospective study in China (2025 · International Journal of Gynecological Cancer · 被引 3)
• Effects of PD-1 inhibitors on ovarian function-based on two-sample mendelian randomization and visualization experimental validation (2025 · Reproductive Toxicology · 被引 2)